Healthleap Raises $38 Million to Expand AI Screening
The San Francisco startup will use the funding to grow its team and screen for over 40 clinical conditions.
Updated on Oct. 30, 2026 in Healthcare
Live Poll
Do you believe AI-powered screening improves healthcare quality in your community hospitals?
Healthleap, a San Francisco-based startup that uses AI to scan patient records for clinical risks, has raised $38 million to expand its operations. The company plans to use the new capital to broaden its screening platform beyond current malnutrition and delirium detection to cover dozens of new conditions.
Why it matters
As the healthcare industry grapples with administrative burnout and diagnostic accuracy, local tech firms are increasingly using AI to automate record reviews. The company now faces the challenge of scaling its services from inpatient settings into outpatient and home care environments.
Healthleap secured $38 million in total funding, reporting a 39% increase in identified malnutrition cases and $11 million in additional reimbursement for a participating health system. The company aims to expand its screening platform from its current focus to encompass more than 40 conditions.
The players
Healthleap
A San Francisco-based startup that builds AI software to identify clinical risks in patient records.
Sequoia Capital
A prominent venture capital firm that co-led the company's seed funding round.
Hummingbird Ventures
The venture firm that led the company's $30 million Series A funding round.
The details
Founded in 2022, the startup uses software to analyze electronic health records and clinician notes to flag risks like delirium and malnutrition. Following its $30 million Series A round led by Hummingbird Ventures and an $8 million seed round led by Sequoia Capital and First Round Capital, the company will grow its engineering, product, and sales teams. The expansion will eventually take the platform into outpatient and home care sectors.
Timeline
2022: Healthleap was founded.
October 30, 2026: The company announced its total $38 million funding raise.
Across the Bay
Healthleap joins a wave of startups leveraging AI-driven clinical decision support systems to automate electronic health record analysis. The platform follows the industry trend of focusing on administrative-heavy workflows to improve both patient outcomes and facility billing efficiency.
Local patients in systems adopting this software may experience earlier detection of conditions like malnutrition and delirium. As the startup expands its hiring and services, this growth will likely manifest in an increased presence of Healthleap technology within regional clinical networks.
The takeaway
The company’s growth signals that AI tools which directly tie to hospital reimbursement models remain a priority for venture capital. Look for the startup to begin rolling out its screening tools to home care providers in the coming months.
Further reading
For more on local innovation in medical technology, explore the Healthcare section.
Source note: This article includes information reported by WeeTracker.
Live Poll
Do you believe AI-powered screening improves healthcare quality in your community hospitals?
